This is a routine CEO succession filing with no financial data — no immediate trading catalyst. Monitor for the new CEO's strategic roadmap update and any changes to pipeline prioritization in upcoming quarters.
Price Chart
Executive Summary
NovaBridge Biosciences announced the appointment of Srishti Gupta, MD MPP as CEO effective July 1, 2026, replacing Xi-Yong (Sean) Fu who resigned amicably. Two board members also resigned, and the President stepped down to Chief Commercial Officer. The CEO change is a routine leadership transition with no financial terms disclosed.
Key Facts
- Srishti Gupta appointed CEO and board member effective July 1, 2026
- Xi-Yong (Sean) Fu resigned as CEO effective June 30, 2026, without disagreement
- Two board members (Emmett T. Cunningham, Jr. and Sean Cao) resigned effective June 30, 2026
- Mark Hagler resigned as President effective July 1, 2026, continuing as Chief Commercial Officer
- Dr. Gupta previously served as CEO of Idorsia Pharmaceuticals and held leadership roles at McKinsey & Company
Financial Impact
No financial figures or compensation details disclosed for the CEO transition
Risk Factors
- Leadership transition could cause short-term operational uncertainty
- No financial details provided to assess material impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-286812 |
| Document: nbp-ex99_1.htm | 0001193125-26-286812 |
| Document: 0001193125-26-286812-index-headers.html | 0001193125-26-286812 |
| Document: 0001193125-26-286812-index.html | 0001193125-26-286812 |
| Document: 0001193125-26-286812.txt | 0001193125-26-286812 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $1.49 | awaiting T+5 | — | $1.37 (−8.05%) |
Oct 25, 2026 1d ago | Press Release | $1.42 | awaiting T+5 | — | $1.37 (−3.52%) |
Oct 23, 2026 3d ago | 6-K | $1.37 | awaiting T+5 | — | $1.37 (+0.00%) |
Oct 13, 2026 13d ago | 6-K | $1.29 $1.43 | ▲ +10.47% | ▲ +11.62% | $1.37 (+6.20%) |
Sep 8, 2026 6w ago | 6-K | $1.78 $1.61 | ▼ −9.55% | ▼ −8.89% | $1.37 (−23.03%) |
Sep 8, 2026 6w ago | 6-K | $1.78 $1.61 | ▼ −9.55% | ▼ −8.89% | $1.37 (−23.03%) |
Aug 20, 2026 9w ago | 6-K | $1.91 $1.89 | ▲ +1.05% | ▲ +2.16% | $1.37 (+28.27%) |
Aug 20, 2026 9w ago | 6-K | $1.91 $1.89 | ▼ −1.05% | ▼ −2.16% | $1.37 (−28.27%) |
Aug 20, 2026 9w ago | Press Release | $1.91 $1.89 | ▲ +1.05% | ▲ +2.16% | $1.37 (+28.27%) |
Jul 24, 2026 13w ago | 6-K | $1.78 $1.60 | ▼ −10.11% | ▼ −11.19% | $1.37 (−23.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers